Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 2, 2005, Pages 249-255

  Fan, Lieying ^a   Tu, Xiaoqing ^a   Zhu, Ye ^a   Zhou, Lin ^a   Pfeiffer, Thomas ^b   Feltens, Ralph ^b   Stoecker, Winfried ^b   Zhong, Renqian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Institute of Experimental Immunology   (Germany)

Author keywords

Autoimmune hepatitis; Gene susceptibility; Polymorphisms; Primary biliary cirrhosis; VDR

Indexed keywords

HLA ANTIGEN; LEUKOCYTE ANTIGEN; VITAMIN D RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; VDR GENE;

EID: 14844331387     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03532.x     Document Type: Article

References (34)

1. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 1999; 31: 929-38.
2. Heathcote EJ. Manage primary biliary cirrhosis. Hepatology 2000; 31: 1005-13.
3. Czaja AJ, Strettell MD, Thomson LJ et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997; 25: 317-23.
4. Qiu de K, Ma X. Relationship between type I autoimmune hepatitis and alleles of HLA-DRB1 in Chinese patients of Shanghai area. Zhonghua Gan Zang Bing Za Zhi 2002; 10: 347-9.
5. Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 1999; 117: 645-52.
6. Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000; 31: 49-53.
7. Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Family primary biliary cirrhosis reassessed: a geographically-based population study. J. Hepatol. 1999; 30: 402-7.
8. Brind AM, Bray GP, Portmann BC et al. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995; 36: 615-17.
9. Agarwal K, Jones DE, Daly AK et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J. Hepatol. 2000; 32: 538-41.
10. Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001; 48: 397-402.
11. Piemonti L, Monti P, Sironi M et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000; 164: 4443-51.
12. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J. Nutr. 1995; 125: 1704S-8S.
13. D'Ambrosio D, Cippitelli M, Cocciolo MG et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-KappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 1998; 101: 252-62.
14. Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J. Cell. Biochem. 1992; 49: 26-31.
15. Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA. Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J. Bone Miner. Res. 1999; 14: 740-6.
16. Kobayashi T, Sugimoto T, Kobayashi A, Chihara K. Vitamin D receptor genotype is associated with cortical bone loss in Japanese patients with primary hyperparathyroidism. Endocr. J. 1998; 45: 123-5.
17. Willing M, Sowers M, Aron D et al. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J. Bone Miner. Res. 1998; 13: 695-705.
18. Springer JE, Cole DE, Rubin LA et al. Vitamin D-receptor geneotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 2000; 118: 145-51.
19. Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 2000; 10: 375-80.
20. Ban Y, Taniyama M, Ban Y. Vitamin D receptor initiation gene polymorphism in Hashimoto's thyroiditis. Thyroid 2001; 11: 607-8.
21. Ban Y, Taniyama M, Yanagawa T et al. Vitamin D receptor initiation codon polymorphism influences, genetic susceptibility to type I diabetes mellitus in the Japanese population. BMC Med. Genet. 2001; 2: 2-7.
22. Fukazawa T, Yabe I, Kikuchi S et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J. Neurol. Sci. 1999; 166: 47-52.
23. Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002; 35: 126-31.
24. Carcia-Lozano JR, Gonzalez-Escribano MF, Valenzuela A et al. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur. J. Immunogenet. 2001; 28: 89-93.
25. Lee CK, Hong JS, Cho YS, Yoo B, Kim GS, Moon HB. Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis. J. Korean Med. Sci. 2001; 16: 188-92.
26. Pasha TM, Dickson ER. Diagnostic criteria, clinical manifestations and natural history of primary biliary cirrhosis. In: Krawitt EL, Wiesner RH, Nishioka M, eds. Autoimmune Liver Diseases, 2nd edn. The Netherlands: Elsevier Science, 1998; 361-80.
27. Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell. Biochem. 2003; 88: 227-33.
28. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc. Natl Acad. Sci. USA 1992; 89: 6665-9.
29. Verbeek W, Gombart AF, Shiohara M, Campbell M, Koeffler HP. Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism. Biochem. Biophys. Res. Commun. 1997; 238: 77-80.
30. Mocharla H, Butch AW, Pappas AA et al. Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J. Bone Miner. Res. 1997; 12: 726-33.
31. Colin EM, Weel AE, Uitterlinden AG et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin. Endocrinol. (Oxf.) 2000; 52: 211-16.
32. 2-adrenegic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl Acad. Sci. USA 2000; 97: 10483-8.
33. Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA. Vitamin D receptor gene Fok 1 polymorphism predicts calcium absorption and bone mineral density in children. J. Bone Miner. Res. 1999; 14: 740-6.
34. Houston LA, Grant SF, Reid DM, Ralston SH. Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. Bone 1996; 18: 249-52.